FDA Approved: SALAGEN — Supplemental Application (Advanz Pharma (US) Corp.)

View source ↗

Summary

The FDA approved a supplemental application for Salagen (pilocarpine hydrochloride) from Advanz Pharma (US) Corp., resulting in changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Radiation-induced Xerostomia
• Sjogren Syndrome
• Xerostomia

Drugs mentioned

• SALAGEN (Pilocarpine hydrochloride)

Snippet

SUPPL AP for SALAGEN (PILOCARPINE HYDROCHLORIDE)